Wall Street analysts forecast that Medical Properties Trust, Inc. (NYSE:MPW) will report $198.46 million in sales for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have provided estimates for Medical Properties Trust’s earnings, with the highest sales estimate coming in at $211.21 million and the lowest estimate coming in at $187.23 million. Medical Properties Trust posted sales of $197.00 million during the same quarter last year, which would indicate a positive year over year growth rate of 0.7%. The firm is expected to report its next quarterly earnings results on Thursday, November 7th.

According to Zacks, analysts expect that Medical Properties Trust will report full-year sales of $787.33 million for the current year, with estimates ranging from $744.68 million to $827.00 million. For the next financial year, analysts expect that the firm will report sales of $905.86 million, with estimates ranging from $667.76 million to $1.10 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, August 1st. The real estate investment trust reported $0.31 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.31. Medical Properties Trust had a return on equity of 6.84% and a net margin of 129.20%. The firm had revenue of $192.55 million for the quarter, compared to analyst estimates of $186.11 million. During the same period last year, the company earned $0.36 earnings per share. The firm’s revenue for the quarter was down 4.6% on a year-over-year basis.

Several brokerages recently commented on MPW. Deutsche Bank raised Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Monday, July 29th. Stifel Nicolaus set a $21.00 target price on Medical Properties Trust and gave the stock a “buy” rating in a research report on Monday, August 12th. SunTrust Banks upgraded Medical Properties Trust from a “hold” rating to a “buy” rating and boosted their target price for the stock from $19.00 to $20.00 in a research report on Tuesday, July 2nd. ValuEngine downgraded Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Zacks Investment Research downgraded Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $18.94.

In other Medical Properties Trust news, Director Michael G. Stewart sold 6,830 shares of the company’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $18.47, for a total transaction of $126,150.10. Following the completion of the sale, the director now directly owns 224,615 shares in the company, valued at $4,148,639.05. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider R Steven Hamner sold 70,000 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $17.77, for a total transaction of $1,243,900.00. Following the sale, the insider now owns 1,312,957 shares of the company’s stock, valued at $23,331,245.89. The disclosure for this sale can be found here. 1.18% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its position in shares of Medical Properties Trust by 1.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 5,704,888 shares of the real estate investment trust’s stock valued at $91,734,000 after purchasing an additional 102,274 shares during the period. Nordea Investment Management AB bought a new stake in Medical Properties Trust during the 4th quarter worth about $95,000. FMR LLC grew its holdings in Medical Properties Trust by 18.2% during the 4th quarter. FMR LLC now owns 4,581,370 shares of the real estate investment trust’s stock worth $73,668,000 after acquiring an additional 705,209 shares during the last quarter. Geode Capital Management LLC grew its holdings in Medical Properties Trust by 22.9% during the 4th quarter. Geode Capital Management LLC now owns 4,659,679 shares of the real estate investment trust’s stock worth $74,927,000 after acquiring an additional 867,172 shares during the last quarter. Finally, Legacy Advisors LLC bought a new stake in Medical Properties Trust during the 1st quarter worth about $93,000. Institutional investors and hedge funds own 80.58% of the company’s stock.

MPW stock traded up $0.33 during trading on Friday, hitting $18.15. The company had a trading volume of 3,154,900 shares, compared to its average volume of 5,178,166. The company has a fifty day moving average price of $17.92 and a two-hundred day moving average price of $18.09. The company has a current ratio of 8.00, a quick ratio of 9.37 and a debt-to-equity ratio of 0.99. The company has a market cap of $7.86 billion, a P/E ratio of 13.25, a P/E/G ratio of 3.31 and a beta of 0.60. Medical Properties Trust has a fifty-two week low of $13.98 and a fifty-two week high of $18.92.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

See Also: What is the Federal Reserve?

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.